Key result
Among patients with atrial fibrillation, a CHADS2 score ≥ 2 was associated with a significantly increased risk of hospitalization for decompensated heart failure (RR 2.96) compared to a score < 2.
Why the study?
There is limited data focusing on the ability of stroke risk scores to predict heart failure decompensation in atrial fibrillation patients.
Do stroke risk scores predict hospitalization for acute decompensated heart failure in patients with atrial fibrillation?
Cohort (n=204)
No
Do stroke risk scores predict hospitalization for acute decompensated heart failure in patients with atrial fibrillation?
Relative Risk: 2.96 (95% CI 1.8–4.87)
p-value: p=<0.0001
Stroke risk scores such as CHADS2 and R2CHADS2 have only modest predictive accuracy for acute decompensated heart failure hospitalizations in patients with atrial fibrillation, limiting their clinical utility for this specific outcome.
Introduction. Atrial fibrillation (AF) is the most frequent hospitalized arrhythmia. It associates increased risk of death, stroke and heart failure (HF). Stroke risk scores, especially CHA 2 DS 2 -VASc, have been applied also for populations with different diseases. There is, however, limited data focusing on the ability of these scores to predict HF decompensation. Methods. We conducted a retrospective observational study on a cohort of 204 patients admitted for cardiovascular pathology to the Cardiology Ward of our tertiary University Hospital. We aimed to determine whether the stroke risk scores could predict hospitalisations for acute decompensated HF in AF patients. Results. C-statistics for CHADS 2 and R 2 CHADS 2 showed a modest predictive ability for hospitalisation with decompensated HF (CHADS 2 : AUC 0.631 p = 0.003; 95%CI 0.560–0.697. R 2 CHADS 2 : AUC 0.619; 95%CI 0.548–0.686; p = 0.004), a marginal correlation for CHA 2 DS 2- VASc (AUC 0.572 95%CI 0.501-0.641 with a p value of only 0.09, while the other scores failed to show a correlation. A CHADS 2 ≥ 2 showed a RR = 2.96, p<0.0001 for decompensated HF compared to a score <2. For R 2 CHADS 2 ≥ 2, RR = 2.41, p = 0.001 compared to a score <2. For CHA 2 DS 2- VASc ≥ 2 RR = 2.18 p = 0.1, compared to CHA 2 DS 2 -VASc <2. The correlation coefficients showed a weak correlation for CHADS 2 (r = 0.216; p = 0.001) and even weaker for R 2 CHADS 2 (r = 0.197; p = 0.0047 and CHA 2 DS 2 -VASc (r = 0.14; p = 0.035). Conclusions. Among AF patients, CHADS 2, CHA 2 DS 2 -VASc and R 2 CHADS 2 were associated with the risk of hospitalisation for decompensated HF while ABC and ATRIA failed to show an association. However, predictive accuracy was modest and the clinical utility for this outcome remains to be determined.
No takes yet. Share an insight, caveat, or question.
Ivănescu et al. (2020) conducted a cohort in Atrial fibrillation (n=204). CHADS2 score ≥ 2 vs. CHADS2 score < 2 was evaluated on Hospitalisation for acute decompensated heart failure (RR 2.96, 95% CI 1.80-4.87, p=<0.0001). Among patients with atrial fibrillation, a CHADS2 score ≥ 2 was associated with a significantly increased risk of hospitalization for decompensated heart failure (RR 2.96) compared to a score < 2.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: